Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Michael Bröker, Francesco Berti & Paolo Costantino. (2016) Factors contributing to the immunogenicity of meningococcal conjugate vaccines. Human Vaccines & Immunotherapeutics 12:7, pages 1808-1824.
Read now
Read now
Vassiliki Papaevangelou & Nikos Spyridis. (2012) MenACWY-TT vaccine for active immunization against invasive meningococcal disease. Expert Review of Vaccines 11:5, pages 523-537.
Read now
Read now
Articles from other publishers (22)
Asmaa Mahmoud, Istvan Toth & Rachel Stephenson. (2022)
Developing an Effective Glycan‐Based Vaccine for
Streptococcus Pyogenes
. Angewandte Chemie International Edition 61:11.
Crossref
Crossref
Asmaa Mahmoud, Istvan Toth & Rachel Stephenson. (2022)
Developing an Effective Glycan‐Based Vaccine for
Streptococcus Pyogenes
. Angewandte Chemie 134:11.
Crossref
Crossref
Timo Vesikari, Ray Borrow, Xavier Da Costa, Stéphane Thomas, Cécile Eymin, Florence Boisnard & Stephen Lockhart. (2018) Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlers. Vaccine 36:52, pages 8019-8027.
Crossref
Crossref
Francesco Berti, Riccardo De Ricco & Rino Rappuoli. (2018) Role of O-Acetylation in the Immunogenicity of Bacterial Polysaccharide Vaccines. Molecules 23:6, pages 1340.
Crossref
Crossref
Timo Vesikari, Ray Borrow, Xavier Da Costa, Patrick Richard, Cécile Eymin, Florence Boisnard & Stephen Lockhart. (2017) Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants. Vaccine 35:3, pages 452-458.
Crossref
Crossref
Julie A. Bettinger, Otto G. Vanderkooi, David W. Scheifele, Scott A. Halperin, James D. Kellner, Anthony Schryvers, Gaston De Serres & Joenel Alcantara. (2016) Do Dose Numbers Matter?. Pediatric Infectious Disease Journal 35:11, pages 1242-1246.
Crossref
Crossref
Roger Baxter, Yaela Baine, Devayani Kolhe, Carmen I. Baccarini, Jacqueline M. Miller & Marie Van der Wielen. (2015) Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults. Pediatric Infectious Disease Journal 34:11, pages 1236-1243.
Crossref
Crossref
Shamez N. Ladhani, Nick J. Andrews, Pauline Waight, Bassam Hallis, Mary Matheson, Anna England, Helen Findlow, Xilian Bai, Ray Borrow, Polly Burbidge, Emma Pearce, David Goldblatt & Elizabeth Miller. (2015) Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule. Vaccine 33:5, pages 648-655.
Crossref
Crossref
Edward T. Clarke, Neil A. Williams, Jamie Findlow, Ray Borrow, Robert S. Heyderman & Adam Finn. (2013) Polysaccharide-Specific Memory B Cells Generated by Conjugate Vaccines in Humans Conform to the CD27+IgG+ Isotype–Switched Memory B Cell Phenotype and Require Contact-Dependent Signals from Bystander T Cells Activated by Bacterial Proteins To Differentiate into Plasma Cells. The Journal of Immunology 191:12, pages 6071-6083.
Crossref
Crossref
Ray Borrow, Raquel Abad, Caroline Trotter, Fiona R.M. van der Klis & Julio A. Vazquez. (2013) Effectiveness of meningococcal serogroup C vaccine programmes. Vaccine 31:41, pages 4477-4486.
Crossref
Crossref
Leszek Szenborn, Hanna Czajka, Jerzy Brzostek, Ryszard Konior, Magalie Caubet, Liliana Ulianov & Maarten Leyssen. (2013) A Randomized, Controlled Trial to Assess the Immunogenicity and Safety of a Heptavalent Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Hib and Meningococcal Serogroup C Combination Vaccine Administered at 2, 3, 4 and 12–18 Months of Age. Pediatric Infectious Disease Journal 32:7, pages 777-785.
Crossref
Crossref
Timo Vesikari, Aino Forstén, Maria Guiseppina Desole, Giuseppe Ferrera, Magalie Caubet, Narcisa Mesaros & Dominique Boutriau. (2013) A Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C Tetanus Toxoid Conjugate Vaccine Is Immunogenic and Well-tolerated When Coadministered With Diphtheria, Tetanus, Acellular Pertussis Hepatitis B–inactivated Poliovirus at 3, 5 and 11 Months of Age. Pediatric Infectious Disease Journal 32:5, pages 521-529.
Crossref
Crossref
Juan Carlos Tejedor, José Manuel Merino, Manuel Moro, Maria-Luisa Navarro, José Espín, Félix Omeñaca, José García-Sicilia, David Moreno-Pérez, Jesús Ruiz-Contreras, Fernando Centeno, Francisco Barrio, Lucia Cabanillas, Marta Muro, Carlos Esporrin, Maria Jose De Torres, Magalie Caubet, Dominique Boutriau, Jacqueline M. Miller & Narcisa Mesaros. (2012) Five-year Antibody Persistence and Safety Following a Booster Dose of Combined Haemophilus influenzae Type b–Neisseria meningitidis Serogroup C–Tetanus Toxoid Conjugate Vaccine. Pediatric Infectious Disease Journal 31:10, pages 1074-1077.
Crossref
Crossref
Ryszard Konior, Teresa Jackowska, Anna Skoczyńska, Waleria Hryniewicz, Piotr Kajfasz, Andrzej Radzikowski, Leszek Szenborn & Jacek Wysocki. (2012) Profilaktyka zakażeń meningokokowych – praktyczne aspekty szczepień. Pediatria Polska 87:5, pages 489-497.
Crossref
Crossref
Raquel Abad & Julio A. V?zquez. (2012) Microbiolog?a y salud p?blica: nuevos retos en vigilancia y control de la enfermedad meningoc?cica. Enfermedades Infecciosas y Microbiolog?a Cl?nica 30:2, pages 53-55.
Crossref
Crossref
Elena Rego Romero, Victoria Nartallo Penas, José Antonio Taboada Rodríguez, Alberto Malvar Pintos, Xurxo Hervada Vidal & María José López Pimentel. (2011) Implementation and impact of a meningococcal C conjugate vaccination program in 13- to 25-year-old individuals in Galicia, Spain. Journal of Public Health 19:5, pages 409-415.
Crossref
Crossref
Ryszard Konior, Leszek Szenborn, Teresa Jackowska, Anna Skoczyńska & Waleria Hryniewicz. (2011) Szczepienia przeciwko meningokokom – aktualne zalecenia i propozycje. Pediatria Polska 86:4, pages 353-359.
Crossref
Crossref
Timo Vesikari, Aino Karvonen, Veronique Bianco, Marie Van der Wielen & Jacqueline Miller. (2011) Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles–mumps–rubella–varicella vaccine during the second year of life: An open, randomized controlled trial. Vaccine 29:25, pages 4274-4284.
Crossref
Crossref
Markus Knuf, Anna Pantazi-Chatzikonstantinou, Ulrich Pfletschinger, Irmingard Tichmann-Schumann, Hartwig Maurer, Lothar Maurer, Thomas Fischbach, Henrike Zinke, Heidemarie Pankow-Culot, Vassiliki Papaevangelou, Veronique Bianco, Marie Van der Wielen & Jacqueline M. Miller. (2011) An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12–23-month-old children. Vaccine 29:25, pages 4264-4273.
Crossref
Crossref
Roger Baxter, Yaela Baine, Kathleen Ensor, Veronique Bianco, Leonard R. Friedland & Jacqueline M. Miller. (2011) Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal ACWY Tetanus Toxoid Conjugate Vaccine in Healthy Adolescents and Young Adults 10 to 25 Years of Age. Pediatric Infectious Disease Journal 30:3, pages e41-e48.
Crossref
Crossref
Anneke Steens, L. Mollema, G.A.M. Berbers, P.G.M. van Gageldonk, F.R. van der Klis & H.E. de Melker. (2010) High tetanus antitoxin antibody concentrations in the Netherlands: A seroepidemiological study. Vaccine 28:49, pages 7803-7809.
Crossref
Crossref
Javier Díez-Domingo, M Victoria Planelles Cantarino, Jose M. Baldó Torrentí, M Isabel Úbeda Sansano, Angels Jubert Rosich, Angel Hernández Merino, Angel Gil de Miguel, Javier Blanco González & Mar Duelo Marcos. (2010) A Randomized, Multicenter, Open-Label Clinical Trial to Assess the Immunogenicity of a Meningococcal C Vaccine Booster Dose Administered to Children Aged 14 to 18 Months. Pediatric Infectious Disease Journal 29:2, pages 148-152.
Crossref
Crossref